Erasca Inc (ERAS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.50B
Last updated: Nov 17, 2026 at 4:41 PM ET
Erasca Inc (ERAS) Stock Chart
Erasca (ERAS) has a latest price of $13.89 on Nov 17, 2026, 42.8% below its 52-week high of $24.28. Its price rose 438.4% over the past 12 months. The month-end price fell 27.5% over the 5 years through Oct 2026, a compound annual decline of 6.2%.
Price Chart
From Jul 2021 to Oct 2026, its highest month-end close was $23.91 in Aug 2021 and its lowest $1.27 in Jun 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ERAS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ERAS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 23.1%, and over 6 months it rose 34.6%. The month-end price rose 521.2% over the 3 years through Oct 2026, a compound annual rate of 83.8%.
| Period | Change |
|---|---|
| 1 month | +2.0% |
| 3 months | -23.1% |
| 6 months | +34.6% |
| 12 months | +438.4% |
| 12 months, with dividends | +438.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +521.2% | +83.8% |
| 5 years | -27.5% | -6.2% |
Price by Year
Its best calendar year was 2025, when the price rose 48.2%, and its weakest was 2022, when it fell 72.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $14.35 | +285.8% |
| 2025 | $3.72 | +48.2% |
| 2024 | $2.51 | +17.8% |
| 2023 | $2.13 | -50.6% |
| 2022 | $4.31 | -72.3% |
Trading Range
The price is 6.7% below its 50-day average of $14.89 and 9.2% below its 200-day average of $15.30.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $13.89 | |
| 52-week high | $24.28 | -42.8% |
| 52-week low | $2.75 | +405.1% |
| 50-day average | $14.89 | -6.7% |
| 200-day average | $15.30 | -9.2% |
Price Risk
Over 3 years, its largest fall from a peak was 67.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.85 |
| Largest fall, 1 year | -59.5% |
| Largest fall, 3 years | -67.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ERAS
What is ERAS's 1-year price change?
Erasca's price rose 438.4% over the past 12 months. With dividends included, the 12-month total return was 438.4%.
What is ERAS's 5-year price change?
Erasca's month-end price fell 27.5% over the 5 years through Oct 2026, a compound annual decline of 6.2%. These figures leave out dividends.
What is ERAS's 52-week high and low?
Erasca's 52-week high is $24.28 and its 52-week low is $2.75. Its latest price of $13.89 on Nov 17, 2026 is 42.8% below the high.
What is ERAS's beta?
Erasca's 1-year beta against the S&P 500 is 1.85, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.5%.
Is the ERAS chart free?
Yes. Advanced Charting for ERAS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ERAS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors